Nantahala Capital Management, LLC
Position in AVR — Anteris Technologies Global Corp.
CIK 1472322
New Canaan, CT
Position in AVR
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$33,325,849
+$2,629,299 QoQ
Shares Held
3,383,335
-38.8% QoQ
Ownership
3.47%
of shares outstanding
% of Portfolio
2.03%
of 13F equity value
Holder Rank
#6
of 135 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Nantahala Capital Management, LLC holds $224,907,183 across 15 Medical Devices names. AVR ranks #2 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BVS |
Bioventus Inc.
|
6,000,279 | $56,642,633 | |
| 2 | AVR |
Anteris Technologies Global Corp.
This page
|
3,383,335 | $33,325,849 | |
| 3 | ESTA |
Establishment Labs Holdings Inc.
|
335,830 | $28,817,572 | |
| 4 | XTNT |
Xtant Medical Holdings, Inc.
|
68,394,000 | $28,725,480 | |
| 5 | APYX |
Apyx Medical Corp
|
3,270,248 | $14,683,413 | |
| 6 | INSP |
Inspire Medical Systems, Inc.
|
269,474 | $12,021,235 | |
| 7 | ITGR |
Integer Holdings Corp
|
111,302 | $10,401,171 | |
| 8 | CATX |
Perspective Therapeutics, Inc.
|
2,325,450 | $7,929,784 |
All Filings in AVR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,325,849 | 3,383,335 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $30,696,550 | 5,530,910 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,629,240 | 2,530,910 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,633,997 | 1,918,666 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,418,994 | 1,693,666 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,055,744 | 1,663,666 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,299,996 | 1,666,666 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||